サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564071

細胞の拡大の世界市場

Cell Expansion

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
細胞の拡大の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細胞の拡大の世界市場は2030年までに869億米ドルに達する見込み

2023年に331億米ドルと推定される細胞の拡大の世界市場は、2023年から2030年にかけてCAGR 14.8%で成長し、2030年には869億米ドルに達すると予測されます。細胞の拡大消耗品は、本レポートで分析したセグメントの1つであり、CAGRは16.0％を記録し、分析期間終了時には424億米ドルに達すると予測されます。細胞の拡大機器セグメントの成長率は、分析期間中CAGR 12.5％と推定されます。

米国市場は91億米ドルと推定、中国はCAGR13.9％で成長予測

米国の細胞の拡大市場は、2023年に91億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに131億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは13.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ13.1%と12.3%と予測されています。欧州では、ドイツがCAGR 10.6%で成長すると予測されています。

世界の細胞の拡大市場- 主要動向と促進要因のまとめ

細胞の拡大は治療と調査にどのような変革をもたらすか？

細胞の拡大は、生物医学研究と先進的治療法の開発において極めて重要なプロセスであり、限られた出発集団から大量の細胞を生産することを可能にします。この技術は、再生医療、腫瘍学、免疫療法など、研究、創薬、治療のために膨大な数の機能的細胞が必要とされる分野において基本的なものです。幹細胞治療の文脈では、細胞の拡大は組織再生や変性疾患の治療に十分な幹細胞の生成を可能にします。がん研究においては、T細胞のような免疫細胞を増殖させる能力が、CAR-T細胞治療のような免疫療法への道を開いた。細胞の生存能力と機能性を維持しながら細胞数を増やす効率的な手段を提供することで、細胞の拡大は臨床と研究の両環境におけるイノベーションを推進しています。バイオリアクター技術や培養液の進歩により、細胞を増殖させるプロセスはよりスケーラブルで正確なものとなり、科学者や臨床医が様々な治療用途のために高品質の細胞を生産できるようになりました。

なぜ細胞の拡大が再生医療と免疫療法に不可欠なのか？

細胞の拡大は、現代ヘルスケアにおいて最も有望な分野である再生医療と免疫療法の進歩に不可欠です。再生医療は、様々な細胞に分化し、傷ついた組織を修復する能力を持つ幹細胞に大きく依存しています。脊髄損傷、心臓病、糖尿病などの症状に対する効果的な治療法を開発するためには、研究者は幹細胞を大量に増殖させなければならないです。その際に課題となるのは、幹細胞の多能性を維持し、必要な細胞に分化する能力を維持することです。一方、免疫療法は、T細胞のような免疫細胞を増殖させることに依存しています。例えば、CAR-T細胞療法の成功は、治療効果を達成するのに十分な数までT細胞を拡大できるかどうかにかかっています。このような治療法の採用が増えるにつれ、細胞の安全性と効力を損なうことなく大量生産をサポートできる堅牢な細胞の拡大システムの必要性が高まっています。細胞ベースの治療に対する需要が増加し続ける中、細胞の拡大の技術は、臨床応用におけるスケーラビリティと規制遵守の課題を満たすために、より洗練されたものになってきています。

技術の進歩は細胞の拡大にどのような革命をもたらしているのでしょうか？

技術の進歩は、細胞の拡大のプロセスに革命を起こし、より効率的で、スケーラブルで、現代科学のニーズに適応できるものにしています。最も重要な技術革新の一つは、バイオリアクターの開発です。バイオリアクターは、細胞増殖のための制御された環境を提供し、生存能力と機能のための最適条件を維持しながら、細胞を大規模に拡大することを可能にします。これらのバイオリアクターは、温度、酸素、栄養レベルなどの重要なパラメーターをモニターし調整する自動化システムを備えており、一貫した再現性のある結果を保証しています。さらに、培養液の技術革新により、特定の細胞タイプに必要な栄養を最適化することが可能になり、拡大した細胞の質と収量がさらに向上しています。細胞が懸濁状態で増殖するための表面を提供するマイクロキャリアは、バイオリアクターの容量を拡大し、高密度の細胞をより効率的に生産できるようにしました。自動化と人工知能（AI）の進歩も重要な役割を果たしており、細胞培養環境におけるリアルタイムのモニタリングと意思決定を可能にしています。これらの技術は、研究者や臨床医が治療用細胞の生産にかかる時間とコストを削減しながら、臨床や産業用途への拡張性を高め、プロセスを合理化するのに役立っています。

細胞の拡大市場の成長を促す要因は何か？

細胞の拡大市場の成長は、細胞ベースの治療に対する需要の増加、バイオプロセス技術の進歩、慢性疾患の有病率の増加など、いくつかの要因によって牽引されています。CAR-T細胞治療や幹細胞治療など、より多くの細胞ベース治療が臨床に導入されるにつれ、信頼性が高くスケーラブルな細胞の拡大手法に対するニーズが急速に高まっています。技術革新、特にバイオリアクターと自動化によって、品質と治療の可能性を維持しながら大量の細胞を生産することが容易になりました。損傷した組織の修復や置換に幹細胞を用いる再生医療における細胞の拡大の利用拡大も、こうした治療に必要な大量の細胞を生産する効率的でスケーラブルなシステムを必要とするため、重要な推進力となっています。さらに、がん、糖尿病、心血管疾患の罹患率の増加は、免疫療法や再生治療など、拡大した細胞に依存する新しい治療法の研究に拍車をかけています。さらに、細胞ベースの治療法の承認における規制の進歩は、バイオプロセシング・インフラへの投資を促し、市場の成長をさらに促進しています。個別化医療に対する消費者の意識が高まるにつれて、カスタマイズされた細胞治療に対する需要が加速し、革新的な細胞の拡大技術の開発に新たな機会が生まれると予想されます。これらの要因が総合的に細胞の拡大市場の急拡大を促し、バイオテクノロジーとヘルスケアにおける重要な成長分野として位置づけられています。

調査対象企業の例（全12件）

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10941

Global Cell Expansion Market to Reach US$86.9 Billion by 2030

The global market for Cell Expansion estimated at US$33.1 Billion in the year 2023, is expected to reach US$86.9 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2023-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the analysis period. Growth in the Cell Expansion Instruments segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.1 Billion While China is Forecast to Grow at 13.9% CAGR

The Cell Expansion market in the U.S. is estimated at US$9.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$13.1 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.1% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Cell Expansion Market - Key Trends and Drivers Summarized

How Is Cell Expansion Transforming Therapeutics and Research?

Cell expansion is a pivotal process in biomedical research and the development of advanced therapies, enabling the production of large quantities of cells from a limited starting population. This technique is fundamental in fields such as regenerative medicine, oncology, and immunotherapy, where vast numbers of functional cells are required for research, drug discovery, or therapeutic use. In the context of stem cell therapy, cell expansion allows for the generation of enough stem cells to support tissue regeneration or to treat degenerative diseases. In cancer research, the ability to expand immune cells, such as T cells, has paved the way for immunotherapies like CAR-T cell treatments, which require billions of engineered immune cells to effectively target and destroy cancerous cells. By providing an efficient means of increasing cell numbers while maintaining their viability and functionality, cell expansion is driving innovation in both clinical and research environments. With advancements in bioreactor technology and culture media, the process of expanding cells has become more scalable and precise, ensuring that scientists and clinicians can produce high-quality cells for a variety of therapeutic applications.

Why Is Cell Expansion Critical for Regenerative Medicine and Immunotherapy?

Cell expansion is indispensable for the advancement of regenerative medicine and immunotherapy, two of the most promising fields in modern healthcare. Regenerative medicine relies heavily on stem cells, which have the ability to differentiate into various cell types and repair damaged tissues. To create effective treatments for conditions such as spinal cord injuries, heart disease, or diabetes, researchers must expand stem cells in large quantities. The challenge lies in maintaining the pluripotency of these cells during the expansion process, ensuring that they retain their capacity to transform into the needed cell types. Immunotherapy, on the other hand, depends on the expansion of immune cells like T cells, which are modified and multiplied to fight diseases such as cancer. The success of CAR-T cell therapy, for instance, hinges on the ability to expand these engineered T cells to sufficient numbers to achieve therapeutic efficacy. The growing adoption of these therapies has increased the need for robust cell expansion systems that can support large-scale production without compromising the safety and potency of the cells. As the demand for cell-based therapies continues to rise, cell expansion technologies are becoming more sophisticated to meet the challenges of scalability and regulatory compliance in clinical applications.

How Are Technological Advancements Revolutionizing Cell Expansion?

Technological advancements are revolutionizing the process of cell expansion, making it more efficient, scalable, and adaptable to the needs of modern science. One of the most significant innovations is the development of bioreactors, which provide controlled environments for cell growth, enabling the expansion of cells on a large scale while maintaining optimal conditions for viability and function. These bioreactors are equipped with automated systems that monitor and adjust critical parameters such as temperature, oxygen, and nutrient levels, ensuring consistent and reproducible results. Additionally, innovations in culture media have made it possible to optimize the nutritional needs of specific cell types, further improving the quality and yield of expanded cells. Microcarriers, which offer a surface for cells to grow in suspension, have expanded the capacity of bioreactors, making them more efficient in producing high cell densities. Advances in automation and artificial intelligence (AI) are also playing a crucial role, enabling real-time monitoring and decision-making in cell culture environments. These technologies help researchers and clinicians streamline the cell expansion process, reducing the time and cost associated with producing therapeutic cells while increasing scalability for clinical and industrial use.

What Factors Are Driving Growth in the Cell Expansion Market?

The growth in the cell expansion market is driven by several factors, including the increasing demand for cell-based therapies, advancements in bioprocessing technologies, and the growing prevalence of chronic diseases. As more cell-based therapies, such as CAR-T cell treatments and stem cell therapies, enter clinical practice, the need for reliable and scalable cell expansion methods is rising rapidly. Technological innovations, particularly in bioreactors and automation, have made it easier to produce large quantities of cells while maintaining their quality and therapeutic potential. The expanding use of cell expansion in regenerative medicine, where stem cells are employed to repair or replace damaged tissues, is another significant driver, as it requires efficient and scalable systems to produce the high volumes of cells necessary for these treatments. Moreover, the growing incidence of cancer, diabetes, and cardiovascular diseases is fueling research into new therapies that depend on expanded cells, such as immunotherapies and regenerative treatments. Additionally, regulatory advancements in the approval of cell-based therapies are encouraging investments in bioprocessing infrastructure, further propelling market growth. As consumer awareness of personalized medicine increases, the demand for customized cell therapies is expected to accelerate, creating new opportunities for the development of innovative cell expansion technologies. These factors are collectively driving the rapid expansion of the cell expansion market, positioning it as a key area of growth in biotechnology and healthcare.

Select Competitors (Total 12 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Expansion - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Cell-Based Therapies Expands Market for Cell Expansion Technologies
    • Advancements in Bioreactor Technology Propel Growth in Scalable Cell Expansion
    • Increasing Focus on Personalized Medicine Strengthens Business Case for Cell Expansion
    • Stem Cell Research and Regenerative Medicine Fuel Market for Optimized Cell Expansion
    • Technological Innovations in 3D Cell Culture Expand Opportunities in Cell Expansion
    • Automation in Cell Expansion Systems Spurs Market Growth in High-Throughput Applications
    • Adoption of CAR-T Cell Therapy Boosts Need for Large-Scale Cell Expansion Solutions
    • Rising Prevalence of Chronic Diseases Accelerates Demand for Advanced Cell Expansion Techniques
    • Emergence of Allogeneic Therapies Creates New Opportunities for Scalable Cell Expansion
    • Shift Toward Automation and AI-Driven Systems Creates New Possibilities in Cell Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Expansion Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Human Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Human Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Animal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Animal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cell Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Cell Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: China 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of World 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of World 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION